Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-03Clinical Trial Results: Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC) [Phase 1, Phase 2]
Results from a Phase 1/2 study evaluating several immunotherapy-based treatments and combinations in patients with urothelial carcinoma (bla…
-
CLINICAL_TRIALS trial_result · 2026-07-22Clinical Trial Update: Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866) [Phase 3]
Phase 3 trial evaluating perioperative pembrolizumab plus neoadjuvant chemotherapy versus perioperative placebo plus neoadjuvant chemotherap…
-
CLINICAL_TRIALS trial_result · 2026-07-07Clinical Trial Results: Project HERO: Health Empowerment & Recovery Outcomes [NA]
Clinical trial results for Project HERO investigating health empowerment and recovery outcomes in cancer patients; study completed and resul…
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC) [Phase 3]
Phase 3 clinical trial evaluating TAR-200 with cetrelimab or TAR-200 alone versus intravesical BCG in BCG-naïve high-risk non-muscle invasiv…
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Results: Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread [Phase 3]
Phase 3 trial comparing Sacituzumab Govitecan to physician's choice in locally advanced or metastatic unresectable urothelial cancer has com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-02Clinical Trial Update: Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread [Phase 3]
Phase 3 trial comparing Sacituzumab Govitecan to physician's choice in locally advanced or metastatic unresectable urothelial cancer has com…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: BCG for Therapeutic Use Phase Ⅲ Clinical Trial [Phase 3]
Phase 3 clinical trial update for therapeutic use of BCG; the study is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04) [Phase 1, Phase 2]
This is a Clinical Trial Update for KEYMAKER-U04, a Phase 1/2 study evaluating new treatments given with enfortumab vedotin and pembrolizuma…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies [Phase 1]
This Phase 1 clinical trial update evaluates Bintrafusp alfa (M7824) and PDS01ADC alone and in combination with SBRT in adults with metastat…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: The Personal Patient Profile Decision Support for Patients With Bladder Cancer [NA]
This clinical trial update notes that the Personal Patient Profile Decision Support tool for bladder cancer has completed, with results post…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Evaluation for NCI Surgery Branch Clinical Research Protocols
NCI's Surgery Branch Clinical Research Protocols are currently recruiting for multiple cancer studies, including synovial sarcoma, melanoma,…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) [Phase 3]
This document announces a Phase 3 clinical trial (MK-2870-031) evaluating sacituzumab tirumotecan for bladder/urothelial cancer, which is cu…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
The document announces the recruitment status for a clinical evaluation of BCDx to monitor recurrence in non-muscle invasive bladder cancer.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy [NA]
A clinical trial is evaluating acupuncture and exercise to manage peripheral neuropathy caused by enfortumab vedotin plus pembrolizumab in p…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003) [Phase 1, Phase 2]
An update on the clinical study MK-3120-003 in bladder cancer, indicating the trial is currently recruiting for Phase 1 and Phase 2.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors [Phase 1]
BeiGene is conducting a Phase 1 safety study to evaluate different doses of BG-68501 in participants with various advanced-stage cancers, an…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study on the Effects of Drugs That Modulate the Endocannabinoid System on Spontaneous and Induced Contractility of the Human Detrusor Muscle
This document reports a clinical trial investigating endocannabinoid-system–modulating drugs and their effects on detrusor muscle contractil…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial [Phase 2]
Phase 2 BRIGHT trial combines immunotherapy with radiation therapy to potentially avoid bladder removal after shrinking muscle-invasive blad…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer [Phase 2]
This update summarizes a Phase 2 study of oral erdafitinib in patients with recurrent non-muscle invasive bladder cancer, including FGFR3-mu…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors [Phase 2]
This clinical trial update outlines a Phase 2 study assessing the combination of nivolumab, ipilimumab, and cabozantinib for various rare ge…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer [Phase 1]
Phase 1 study evaluating 68Ga-PSMA-PET/CT imaging in people with bladder cancer or skin cancer.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
This clinical trial update reports that recruitment is ongoing for a study comparing intravesical therapy and surgical options for bladder c…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors [Phase 1]
Phase 1 clinical trial update showing LY4052031 being studied in advanced or metastatic urothelial cancer and other solid tumors; the study …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
A clinical trial update describes en-bloc transurethral resection of bladder tumor (En-bloc TURBT) using a redesigned resectoscope device; t…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment
A completed clinical trial evaluating cancer outcomes in patients treated with dapagliflozin in addition to other antidiabetic therapies.